October 9, 2012
•
Research Updates
October 9 -- Eli Lilly announced encouraging results yesterday involving their experimental drug Solanezumab. Solanezumab is an antibody aimed at lowering beta...
October 2, 2012
Cure Alzheimer’s Fund Research Consortium member and funded researcher Steven L. Wagner, Ph.D., Principle Investigator, Department of Neurosciences;...
September 28, 2012
•
Social Activism
Follow these easy instructions to be featured in our upcoming video: Read all instructions first, and then click on the link, below.
September 20, 2012
•
From the Founders
by Jeffrey Morby, Cure Alzheimer’s Fund chairman and co-founder
September 5, 2012
•
Research Updates
A new study by David Holtzman of Cure Alzheimer’s Fund’s Research Consortium published by the journal “Science Translational Medicine”...
September 4, 2012
•
Social Activism
After reading Barbara Kingsolver’s Animal Dreams in Honors English at Scituate High School, Lexie Fidas, 15, was given another class assignment—to...
August 31, 2012
Chairman and Co-Founder Jeffrey L. Morby discusses the focus of Cure Alzheimer's Fund: to conquer the problem of Alzheimer's disease with a clearly...
August 30, 2012
•
Research Updates
A study just published in the New England Journal of Medicine points to the value of conducting a new series of Alzheimer's prevention studies, suggests...
